The first reported case of congenital Heinz body hemolytic anemia was subsequently shown to be caused by an unstable hemoglobin, Hb Bristol [p67(E11) Val-Asp]. This has become one of the classic models of an unstable hemoglobin, the hydrophilic aspartate disrupting the hydrophobic heme pocket. We have restudied this original case, who remains clinically well after nearly 50 years of severe hemolysis with a hemoglobin level of about 7 g/dL and two unrelated Japanese cases. Surprisingly, all three cases show the same DNA changes, predicting a valine to methionine change at j367, LTHOUGH DNA codes for 20 primary amino acids, A more than 140 different residues have been identified in proteins, because of varied posttranslational modifications.' The majority are relatively simple reactions involving enzymatic modification of the side chains of amino acids to enhance or determine the properties of the particular protein; these processes include acetylation, phosphorylation, hydroxylation, and glycation.' There are also a number of posttranslational modifications of hemoglobin A, such as glycation and carbamoylation, but these are due mostly to nonspecific metabolic effects that alter the chemical environment of the hemoglobin, rather than direct results of the properties of hemoglobin itself. However, amino acid substitutions producing unstable hemoglobins have been shown to cause a number of specific covalent posttranslational modifications (these will be reviewed in detail in the Discussion).
A more than 140 different residues have been identified in proteins, because of varied posttranslational modifications. ' The majority are relatively simple reactions involving enzymatic modification of the side chains of amino acids to enhance or determine the properties of the particular protein; these processes include acetylation, phosphorylation, hydroxylation, and glycation.' There are also a number of posttranslational modifications of hemoglobin A, such as glycation and carbamoylation, but these are due mostly to nonspecific metabolic effects that alter the chemical environment of the hemoglobin, rather than direct results of the properties of hemoglobin itself. However, amino acid substitutions producing unstable hemoglobins have been shown to cause a number of specific covalent posttranslational modifications (these will be reviewed in detail in the Discussion).
Unstable hemoglobin variants are characterized by the reduced solubility of the hemoglobin tetramer in the red cell in the peripheral blood.' Most result from mutations of amino acids in key positions, for example heme-or @-contact points; often the variant amino acid has different properties to the original, such as changes in hydrophobicity, size, or charge. Apart from the resulting hemolysis and anaemia, more subtle effects can include changes in oxygen affinity and methemoglobinaemia. Mutations can also alter the structure of the molecule such that posttranslational changes can occur, either of the variant amino acid itself or of other residues exposed by changes in the conformation of the molecule. More rarely, so-called silent modifications occur, in which one primary amino acid is converted to another primary amino acid. Detection of these changes, particularly the silent type, can be difficult, but is important to fully determine the phenotype of the m~t a t i o n .~.~
In the 1960s and 1970s hemoglobin variants were characterized in detail at the protein level, although the proposed mutations could not be confirmed by DNA analysis. With the advent of reliable and easy methods of DNA sequencing, novel hemoglobin variants have often been described at the DNA level only, with little information on the resulting phenotype and the nature of the mutant protein, such as its oxygen affinity, stability, and biosynthetic properties. Both approaches are incomplete. We have reinvestigated the patient who was the subject of the first description of idiopathic Heinz body anaemia, and who was subsequently shown to have hemoglobin Bristol. Using both DNA and protein analrather than the expected aspartate. Further analysis with electrospray ionization mass spectrometry and globin chain biosynthesis strongly suggests that this anomaly is because of a novel posttranslational mechanism, with slow conversion of the translated methionine into an aspartate residue. The proximity of the heme and oxygen may be important in facilitating the reaction. These findings show the importance of complete characterization of variant hemoglobins using protein, DNA, and biosynthetic analyses. ysis, we show that the original characterization of hemoglobin Bristol as 067(Ell)Val-Asp was incorrect, in that a silent posttranslational modification of Met -+ Asp was mistaken for the primary mutation, which is in fact p67(Ell)Val-Met. We have also restudied two subsequent patients reported as having hemoglobin Bristol following protein sequencing, in whom the same confusion occurred. Using this approach, we are able to describe a novel posttranslational modification, in which the variant methionine amino acid residue is converted to an aspartate, probably catalysed by the neighboring heme group and oxygen. This study emphasizes the importance of analysing both protein and DNA to fully characterize hemoglobin variants. concentrator (MPC-E; Dynal; Wirral) as described? The singlestranded DNA was sequenced directly using Sequenase (US Biochemicals, Cleveland, OH) and a series of primers. The noncoding strand of DNA from the original hemoglobin Bristol case was sequenced using the following primers, covering the three exons of the gene: exon 3 5'-GCAGCCTCACCTTCllTCATGG-3', exon 2 5'-CA'lTCGTCTGIXTCCCATTCTA-3', exon 1 5'-AATAGA-CCAATAGGCAGAG-3'. The sequence of the exon 2 region containing the hemoglobin mutation was checked by sequencing the coding strand using the primer 5'-GACTCTTGGGTITCTGATAG-3'. The sequence was confirmed using allele-specific amplification" of the Hb Bristol mutation, and the primers shown in Table 1 .
The two Japanese Hb Bristol cases were sequenced using the 5'SP4 primer to show exon 2, including the supposed site for the hemoglobin Bristol mutation. Globin chain biosynthesis. A time-course incubation of heparinized reticulocytes with tritiated leucine was followed over one hour, and globin prepared and the chains separated using cation exchange chromatography. Specific activities were calculated following dialysis of the peak fractions against 0.5% formic acid.".'* Whole blood was diluted 1:500 in 50% aqueous acetonitrile containing 0.2% formic acid, before analysis by electrospray ionization mass spectrometry (ESI-MS). Ten microliters was injected into the electrospray ion source of the Quattro I1 mass spectrometer (VG Organic, Altrincham, UK). Three and a half minutes of data were collected from each sample and the mass scale internally calibrated using the multiply-protonated a-globin peaks. Background-subtracted spectra were transformed onto a true molecular weight scale using the maximum entropy based procedure supplied with the mass spectrometer.'? Analysis was also performed on the separated pre-8-globin peak (X, see Fig 3) . Globin was prepared by acid-acetone precipitation, the globin dissolved in 8 m o m urea and the a, 8 , and pre-/3 peaks separated by cation exchange chromatography. The peak fractions were then dialyzed against 0.5% formic acid to remove the urea, and lyophilized before ESI-MS.
Mass spectrometry.

RESULTS
Case reports. In 1952, Cathie reported the case of a 5-year-old boy, with a Heinz body hemolytic anaemia, present from birth, and with no obvious precipitating toxic agents.I4 The child was first seen aged 16 months, when he was jaundiced, with a hemoglobin of 7 g/dL, punctate basophilia and 37% reticulocytes. A diagnosis of congenital acholuric jaundice was made and the spleen removed. He received blood transfusions regularly until he was 15, when they were stopped with no adverse effects.
In the late 196Os, he was reinvestigated in the light of the discovery of unstable hemoglobin ~ariants.'~ Hemoglobin instability was demonstrated using the heat stability test and the precipitated hemoglobin analysed using fingerprinting of the tryptic digest. An abnormal PT9 peptide was shown, and amino acid sequencing of this suggested that the N-terminal valyl residue was replaced by an aspartyl or asparaginyl residue. Further analysis using the Dansyl chloride method confirmed the substitution of valine by aspartic acid at residue 67 of the P-globin chain; this was called hemoglobin Bristol. The introduction of a charged residue into the hydrophobic heme pocket was said to account for the instability.
The patient is now 47 years old and is in good health. His steady state hemoglobin is 7.5 g/dL. He has suffered one hemolytic crisis following food poisoning in 1991 but did not need a transfusion. He had two subarachnoid hemorrhages in his twenties, with no residual deficit. He has valvular heart disease following rheumatic fever age 16. None of his relatives, including parents and five siblings, suffer from hemolysis or anemia. analysis. The clinical and hematological features seem similar." The hematological data from these cases are summarized in Table 2 .
Blood films from the UK case showed bizarre anisopoikilocytosis with very marked basophilic stippling. Eighty percent of the cells showed Heinz bodies. Isoelectric focusing showed no abnormal bands. Isopropanol and heat stability tests were positive after less than a minute.
Both DNA strands of the &globin gene of the UK case of Hb Bristol were sequenced, and showed the heterozygous mutation GTG to ATG at codon 67 (Fig  1) . This predicts an amino acid change of valine to methionine, not the expected aspartic acid. This mutation was confirmed by allele-specific amplification using the primers shown in Table I , which selectively amplified the ATG codon in position 67 of the Hb Bristol case (Fig.2) . No other mutations were found in the rest of the &globin gene. The coding strands of both Japanese cases of Hb Bristol were also sequenced and the same mutation found as in the UK case.
After 60 minutes the total counts biosynthesis ratio was alp = 1.2, suggesting no significant imbalance in the rate of synthesis of the globin chains. It is interesting that although the 0.d. 280 nm trace shows a significant peak in the pre-0 region, where one would expect a variant &chain with a valine-aspartate substitution to run, there is no corresponding peak of radioactivity at this point (Fig 3) . The time course incubation of the UK case is shown in Fig 4. The rate of increase of specific activity of both a and p chains is nonlinear, asymptotically
approaching maximum values. This is the expected pattern with unstable hemoglobin variants.
Analysis by ESI-MS of whole globin showed the anticipated peaks corresponding to the calculated masses for normal a chain (15, 126 heavier, in the ratio 4:3, respectively, were apparent (Fig 5) . These mass increments are identical to those calculated for the aspartate-67 and methionine-67 variants of normal pglobin. Analysis of the pre-P peak (X, Fig 3) , which one would expect to consist mostly of aspartate-67 on the basis of its altered charge, showed a main peak of 15,883 daltons, 16 daltons heavier than normal &globin, as predicted ( Fig  6) . Additional peaks corresponding to the 8 m o m ureamediated carbamoylation of the @-globin are also apparent. The apparent presence of normal P-globin in the pre-P ESI-MS analysis probably results from incomplete separation of the globins.
DISCUSSION
The UK subject with hemoglobin Bristol has survived in good health for nearly 50 years, suffering no obvious prob- lems related to his hemoglobinopathy, despite his persistent severe hemolysis. He has not accumulated excessive iron. The first Japanese case appears to be following a similar course. The second Japanese and Russian cases are more severely affected, with a lower hemoglobin and growth retardation. The reason for this variable phenotype is not clear; splenectomy resulted in marginal increases in hemoglobin in the UK, Japanese 1 and Russian cases, although clinical improvement was said to follow.
The DNA sequencing appears to disagree with the protein analysis; the latter has been performed on three separate occasions and in two different laboratories, making a technical error unlikely. A possible explanation involves the oxidation of the variant methionine residue to methionine sulfoxide or methionine sulfone.18 Both these reactions are thought to occur commonly in proteins and could explain some of the results: the oxidized derivatives could cause the peak seen on cation-exchange chromatography and travel close to aspartate in many amino acid analyzers, thus "impersonating" aspartate. However, depending on the conditions, the prolonged acid hydrolysis used in the amino acid sequencing might be expected to reduce these derivatives back to methionine, making the oxygenation undetectable. The mass spectrometry and globin chain synthesis shed further light. ESI-MS shows there are proteins present with masses corresponding to a-chains, normal P-chains, aspartate-67 and methionine-67 P-chains (Fig 5) . It should be noted that more than one modification may result in the same or very similar mass changes: for example a modification producing a homoserinyl y-aldehyde, a possible product resulting from methionine oxidation, would result in a P-globin of mass 15,867 daltons, identical to that of normal P-globin. Further relevant examples of modifications and their associated mass changes are given in Table 3 . Separation of the globin chains by cation exchange chromatography shows three main protein peaks, corresponding to a chains, normal p chains (and variants with no charge alteration eg, valine to methionine) and / 3 chains with a valine to aspartate (or glutamate tion. ESI-MS shows that the pre-p peak is 16 daltons heavier than the normal (Fig 6) , consistent with a valine to aspartate substitution. After 1 hour, there is little or no radioactive incorporation into the 'aspartate' peak, suggesting that this forms via a slow posttranslational modification of the pchain (Fig 3) . Protein analysis has localized the valine to aspartate change to p67 while the DNA analysis finds the valine to methionine substitution in the same position. Hence, protein, DNA, biosynthetic and mass spectrometric analyses suggest a p67 valine to methionine substitution A number of examples of posttranslational modification of hemoglobin have been described. Globin translation is initiated with an unblocked methionine residue that is released when the nascent chain reaches about 30 amino acids in length; the N-terminal can then be cotranslationally acetylated, depending on the amino acid. In globin chains, the N-terminal is valine which strongly inhibits the acetylation." However, mutations involving the N-terminal amino acids For personal use only. on August 16, 2017. by guest www.bloodjournal.org From The exact mechanisms involved in the deamidation have not been worked out, and may be different for each of the variants; important factors seem to be a high degree of flexibility in the region of the mutation and the proximity of a histidine residue.
The posttranslational oxidation of methionine residues to their sulfoxides or sulfones is well-documented, but we are unaware of any reports of the modification of methionine to aspartyl residues. The presence, at a low level of the p methionine-67 sulfoxide(s) or sulfone cannot be ruled out and it may be that they are transient intermediates in the production of aspartate-67 variant. Previous studies on the oxidation of the methionine residues of elastase to their sulfoxides have shown that oxidation of intemal methionines in hydrophobic regions is very slow or n~nexistent.'~ The 067 residue is in a hydrophobic region and is one of the heme contact points. Hence the variant methionine is in close proximity to both the iron and the oxygen of oxyhemoglobin. Thus, it is reasonable to suppose that an oxy-heme complex is involved in the conversion of the methionine to an aspartyl residue. Minimally, this requires a four electron oxidation of the y-carbon of methionine. The mechanism by which this oxidation occurs is open to speculation and may be mediated by free radical (dioxygen) or anionic (superoxide or peroxide) species. In theory the oxidation process may result from reaction of 67-methionine (or its sulfoxide(s) or sulfone) with a dioxygen molecule to produce a thioester and a water molecule (Fig 7) . Subsequent hydrolysis of the thioester will produce aspartate. Such a process has a precedent in the enzyme catalyzed oxidation of the substrate
valine by the non-heme ferrous-dependent oxygenase isopenicillin N ~ynthase.'~ A number of other mechanisms are possible. It is also noteworthy that because it is possible to isolate @globin with a methionine at residue 67, the conversion of methionine-67 to aspartate-67 is not a rapid process, and thus the autocatalytic role of a 'normal' oxy-heme species in the oxidation is questionable.
Although this type of posttranslational modification has not been described before, it is possible that it occurs in other hemoglobin variants in which a methionine is substituted into one of the heme, or near heme, contact points. In variants characterized only by protein analysis, this may have been described as an amino acid being replaced by an aspartate residue at one of the heme contact points, as for hemoglobin Bristol: this group includes Hb J Altgeld Gardens," Hb Yoshiz~ka,'~ and Hb J-R~vigo.~* Similarly, identification of variants involving methionine by DNA sequencing alone might miss a posttranslational modification to aspartate. Interestingly, the a-globin counterpart of Hb Bristol, Hb Evans (a262[E1 11Val-Met) has been identified both by DNA and protein characterisation with no evidence of posttranslational modification.'' Five hemoglobin variants have been described at the p67 position, summarized in Table 4 . It was noted in the original characterization of Hb Bristol that it is not possible to derive each of the amino acids found in Hb Sydney, Hb M-Milwaukee, and Hb Bristol from a single base change in any single codon for ~a1ine.I~ In fact, it is not possible to derive a codon for aspartate (GAC or GAT) from the consensus sequence (GTG) by a single amino acid change. One of the published 
